輸入代號或公司名稱後按 Enter
4105

東洋

+0.10 (+0.13%)最後更新 2026-09-11
台灣 · 上櫃 · 生技醫療業
77.50569成交張數11.12本益比2.77股價淨值比5.81%殖利率2026-09-11資料日期

每股盈餘

柱為單季 EPS,線為近四季合計;近十年

季度單季 EPS年增近四季 EPS歸屬母公司淨利(億)淨利率ROE(季)ROE(近四季)
2026Q21.6442.6%6.974.0624.6%6.01%26.38%
2026Q11.7813.4%6.484.4329.1%6.42%25.40%
2025Q41.22-43.3%6.273.0318.2%4.30%22.29%
2025Q32.3355.3%7.205.8031.9%8.90%27.39%
2025Q21.159.5%6.372.8518.8%4.63%26.41%
2025Q11.5738.9%6.273.9126.8%6.08%26.89%
2024Q42.15159.0%5.835.3531.2%8.25%22.84%
2024Q31.50-0.7%4.513.7324.3%6.20%18.62%
2024Q21.05-15.3%4.522.6219.0%4.64%20.08%
2024Q11.1317.7%4.712.8122.1%4.91%22.22%
2023Q40.83-15.3%4.542.0512.4%3.48%19.46%
2023Q31.5111.0%4.693.7626.3%6.72%20.71%
2023Q21.247.8%4.543.0924.5%5.92%21.70%
2023Q10.965.5%4.452.3920.5%4.46%21.06%
2022Q40.98-29.5%4.402.4516.0%4.40%20.22%
2022Q31.3634.6%4.813.3825.5%6.44%23.15%
2022Q21.15784.6%4.462.8424.4%5.42%20.82%
2022Q10.9111.0%3.442.2821.9%4.28%15.46%
2021Q41.3931.1%3.353.4423.4%6.86%15.67%
2021Q31.0113.5%3.022.5323.9%4.84%14.99%
2021Q20.13-82.7%2.900.323.1%0.57%13.58%
2021Q10.82-19.6%3.522.0321.1%3.67%15.40%
2020Q41.06715.4%3.722.6321.8%4.94%16.77%
2020Q30.89-29.9%2.792.2221.7%4.37%12.91%
2020Q20.75-27.9%3.171.8620.6%3.46%15.34%
2020Q11.02-13.6%3.462.5423.2%4.49%14.52%
2019Q40.13-91.2%3.620.312.8%0.56%15.83%
2019Q31.27-8.0%4.973.1627.5%5.85%22.39%
2019Q21.04-47.7%5.082.5923.7%4.55%24.20%
2019Q11.1814.6%6.032.9426.4%4.93%25.19%
2018Q41.48-38.8%5.883.6733.6%6.50%25.86%
2018Q31.3823.2%6.823.4337.9%6.44%32.53%
2018Q21.99103.1%6.564.9549.6%9.04%32.91%
2018Q11.0315.7%5.552.5624.6%4.54%24.48%
2017Q42.4274.1%5.416.0252.0%11.53%24.73%
2017Q31.1231.8%4.382.7826.6%5.74%21.90%
2017Q20.98-31.5%4.112.4426.2%4.77%21.48%
2017Q10.89-21.2%4.562.2123.4%4.07%21.01%
2016Q41.394.803.4536.2%6.65%
2016Q30.852.1322.7%4.35%